Novavax to raise $200 million through stock offering to fund COVID-19 vaccine

9:24am PDT - June 15th, 2020    novavax stock - Reuters

Novavax Inc said on Monday it would raise fresh capital through a $200 million preferred stock offering as it races to develop a vaccine for the new coronavirus, sending its shares up 10.5%.